Capricorn Fund Managers’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Capricorn Fund Managers's JAZZ Position: Q3 2026 in Review
Capricorn Fund Managers sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2026, closing a stake of 6,100 shares — an estimated $1.47M sold.
Capricorn Fund Managers first reported a position in JAZZ in Q4 2025 and held it in 2 quarters. The position peaked at $1.7M in Q4 2025. 669 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.
- Capricorn Fund Managers reported no remaining Jazz Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Capricorn Fund Managers sold 6,100 Jazz Pharmaceuticals shares in Q3 2026, an estimated $1.47M.
- Capricorn Fund Managers first reported a position in Jazz Pharmaceuticals in Q4 2025 and held it in 2 quarters.
- Capricorn Fund Managers's Jazz Pharmaceuticals position peaked at $1.7M in Q4 2025.
- 669 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.
Based on Capricorn Fund Managers's 13F filing for Q3 2026, filed 3 Nov 2026.